Directors of the California stem cell agency reconvened in public after a lengthy closed-door session during which they were believed to be discussing the election of a person to replace Robert Klein as chairman of the $3 billion enterprise.
The Internet audiocast of the event was up briefly but has now vanished.
No comments:
Post a Comment